To further determine the ability of PADI2 to promote CRC metastasis, the effects of PADI2 siRNA transfection were verified in both SW620 (p<0.0001) and SW480 (p=0.0002) cells by Western blot analysis (Figure 6A). This evidence concerns the gene PADI2 and colorectal carcinoma.